NCT02172105View on ClinicalTrials.gov

Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 1744 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY